Why Teva Pharmaceutical Shares Dropped 7% in October

Image source Getty Images What happened After U S patent regulators invalidated the third of five patents protecting Copaxone sales shares in Teva Pharmaceutical NYSE TEVA fell steadily throughout October to finish down 7 1 on the month 160 according to S amp